Literature DB >> 11877705

Differential regulation of matrix metalloproteinase activities in abdominal aortic aneurysms.

Borhane Annabi1, Daniel Shédid, Pierre Ghosn, Rhoda L Kenigsberg, Richard R Desrosiers, Michel W Bojanowski, Edith Beaulieu, Edgar Nassif, Robert Moumdjian, Richard Béliveau.   

Abstract

BACKGROUND: The increased synthesis of matrix metalloproteinases (MMPs) by aortic smooth muscle cells (SMCs) is thought to be involved in the etiopathogenesis of abdominal aortic aneurysms (AAAs), but the functional regulation and the activation states of these MMPs remain unclear. In this study, we assessed the expression levels and the functional regulation of several MMPs in the pathogenesis of AAAs.
METHODS: Human healthy aorta and AAA specimens were homogenized, and the proteolytic activities of MMP-2 and MMP-9 and of the macrophage metalloelastase (MMP-12) were assessed with zymography. Protein expression of MMP-1, MMP-12, membrane-type 1 MMP (MT1-MMP), tissue inhibitor of MMP 1 (TIMP-1), TIMP-2, TIMP-3, alpha-actin, and beta-actin was analyzed with electrophoresis on sodium dodecyl sulfate gels and immunoblotting.
RESULTS: MMP-1, MMP-9, and MMP-12 zymogen levels and proteolytic activities were increased in AAAs when compared with healthy aorta. A severe reduction in alpha-actin--positive vascular SMCs was observed in all the AAA specimens and was correlated with an increase in TIMP-3 but not TIMP-1 or TIMP-2 potential activities. Although pro--MMP-2 activity was decreased, the extent of activated MMP-2 remained unaffected in the AAAs. In accordance with this result, a highly activated MT1-MMP form was also observed in AAAs.
CONCLUSION: These data suggest that chronic aortic wall inflammation is mediated by macrophage infiltration, which may account for the destruction of medial elastin, as reflected by SMC down regulation, through increased levels of active MMP-1 and MMP-12. Moreover, altered MT1-MMP proteolytic turnover and differential regulation of TIMP expression in AAAs suggest that tight regulatory mechanisms are involved in the molecular regulation of MMP activation processes in the pathogenesis of AAAs.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11877705     DOI: 10.1067/mva.2002.121124

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  32 in total

Review 1.  Matrix metalloproteinases, a disintegrin and metalloproteinases, and a disintegrin and metalloproteinases with thrombospondin motifs in non-neoplastic diseases.

Authors:  Takayuki Shiomi; Vincent Lemaître; Jeanine D'Armiento; Yasunori Okada
Journal:  Pathol Int       Date:  2010-07       Impact factor: 2.534

Review 2.  Matrix metalloproteinases and descending aortic aneurysms: parity, disparity, and switch.

Authors:  Tom P Theruvath; Jeffrey A Jones; John S Ikonomidis
Journal:  J Card Surg       Date:  2011-09-29       Impact factor: 1.620

3.  A failure of matrix metalloproteinase inhibition in the prevention of rat intracranial aneurysm formation.

Authors:  T J Kaufmann; W F Marx; D F Kallmes
Journal:  Neuroradiology       Date:  2006-01-04       Impact factor: 2.804

Review 4.  Chemistry and pharmacology of 4-hydroxylonchocarpin: a review.

Authors:  Victor Kuete; Jaures A K Noumedem; Frederic Nana
Journal:  Chin J Integr Med       Date:  2013-06-20       Impact factor: 1.978

5.  Direct relationship between cell density and FDG uptake in asymptomatic aortic aneurysm close to surgical threshold: an in vivo and in vitro study.

Authors:  Cecilia Marini; Silvia Morbelli; Riccardo Armonino; Giovanni Spinella; Mattia Riondato; Michela Massollo; Francesca Sarocchi; Bianca Pane; Carla Augeri; Luca Abete; Giorgio Ghigliotti; Daniela Palmieri; Francesco Fiz; Giuseppe Cittadini; Ezio Fulcheri; Domenico Palombo; Gianmario Sambuceti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-10-20       Impact factor: 9.236

6.  Tissue reaction to three different types of tissue glues in an experimental aorta dissection model: a quantitative approach.

Authors:  Kirsti Witter; Zbynek Tonar; Vít Martin Matejka; Tomás Martinca; Michael Jonák; Slavomír Rokosný; Jan Pirk
Journal:  Histochem Cell Biol       Date:  2009-11-10       Impact factor: 4.304

7.  FXa inhibition by rivaroxaban modifies mechanisms associated with the pathogenesis of human abdominal aortic aneurysms.

Authors:  Guillermo Moñux; Jose J Zamorano-León; Pablo Marqués; Bernardo Sopeña; J M García-García; G Laich de Koller; Bibiana Calvo-Rico; Miguel A García-Fernandez; J Serrano; Antonio López-Farré
Journal:  Br J Clin Pharmacol       Date:  2017-08-27       Impact factor: 4.335

8.  Regulation of membrane type-1 matrix metalloproteinase activity and intracellular localization in clinical thoracic aortic aneurysms.

Authors:  John S Ikonomidis; Elizabeth K Nadeau; Adam W Akerman; Robert E Stroud; Rupak Mukherjee; Jeffrey A Jones
Journal:  J Thorac Cardiovasc Surg       Date:  2016-11-14       Impact factor: 5.209

Review 9.  Elastin and collagen fibre microstructure of the human aorta in ageing and disease: a review.

Authors:  Alkiviadis Tsamis; Jeffrey T Krawiec; David A Vorp
Journal:  J R Soc Interface       Date:  2013-03-27       Impact factor: 4.118

10.  Effect of statin therapy on serum activity of proteinases and cytokines in patients with abdominal aortic aneurysm.

Authors:  Bernd Muehling; Alexander Oberhuber; Hubert Schelzig; Gisela Bischoff; Nikolaus Marx; Ludger Sunder-Plassmann; Karl H Orend
Journal:  Vasc Health Risk Manag       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.